tiprankstipranks
Advertisement
Advertisement

DYN Stock Latest News

Dyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
Company AnnouncementsDyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
2d ago
DYN
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
5d ago
DYN
RNA
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
PremiumRatings
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
1M ago
DYN
Dyne Therapeutics announces data from Phase 1/2 Deliver trial of z-rostudirsen
PremiumThe Fly
Dyne Therapeutics announces data from Phase 1/2 Deliver trial of z-rostudirsen
1M ago
DYN
Dyne Therapeutics initiates Phase 3 Harmonia trial of Z-Basivarsen in DM1
PremiumThe Fly
Dyne Therapeutics initiates Phase 3 Harmonia trial of Z-Basivarsen in DM1
1M ago
DYN
Controversial Prasad leaving FDA, NYT reports
PremiumThe FlyControversial Prasad leaving FDA, NYT reports
1M ago
AZN
BMY
Dyne Therapeutics price target lowered to $47 from $50 at Morgan Stanley
Premium
The Fly
Dyne Therapeutics price target lowered to $47 from $50 at Morgan Stanley
2M ago
DYN
Dyne Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
Premium
The Fly
Dyne Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
2M ago
DYN
Dyne Therapeutics reports Q4 EPS (76c), consensus (76c)
PremiumThe Fly
Dyne Therapeutics reports Q4 EPS (76c), consensus (76c)
2M ago
DYN
Dyne Therapeutics announces upcoming presentations at MDA Conference
PremiumThe Fly
Dyne Therapeutics announces upcoming presentations at MDA Conference
2M ago
DYN
Dyne announces MHLW in Japan granted ODD for zeleciment basivarsen
PremiumThe Fly
Dyne announces MHLW in Japan granted ODD for zeleciment basivarsen
3M ago
DYN
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
PremiumCompany Announcements
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
3M ago
8K
DYN
Dyne Therapeutics Appoints Vikram Karnani to Board
PremiumCompany AnnouncementsDyne Therapeutics Appoints Vikram Karnani to Board
4M ago
8K
DYN
Dyne Therapeutics appoints Vikram Karnani to board of directors
Premium
The Fly
Dyne Therapeutics appoints Vikram Karnani to board of directors
4M ago
DYN
COLL
Dyne Therapeutics price target lowered to $36 from $38 at Evercore ISI
Premium
The Fly
Dyne Therapeutics price target lowered to $36 from $38 at Evercore ISI
4M ago
DYN
Dyne Therapeutics price target raised to $39 from $36 at Stifel
PremiumThe Fly
Dyne Therapeutics price target raised to $39 from $36 at Stifel
4M ago
DYN
Dyne Therapeutics Announces Upsized Public Offering
PremiumCompany Announcements
Dyne Therapeutics Announces Upsized Public Offering
4M ago
8K
DYN
Amazon initiated, GE Vernova upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Amazon initiated, GE Vernova upgraded: Wall Street’s top analyst calls
4M ago
M
NE
Oppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
PremiumThe Fly
Oppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
4M ago
DYN
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
PremiumThe FlyDyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
4M ago
DYN
Dyne Therapeutics 18.98M share Secondary priced at $18.44
Premium
The Fly
Dyne Therapeutics 18.98M share Secondary priced at $18.44
4M ago
DYN
Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
Premium
The Fly
Midday Fly By: Nvidia can ship H200s to China, Campbell’s reports Q1 beat
4M ago
C
F

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >